Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Miacalcic Ampoules 100IU°


Contraindicated

Not recommended
Manque de données
Miacalcic Ampoules 100IU° :
Type Medicine Withdrawn
Originator B
Agent Khalil Fattal & Fils
Distributor Khalil Fattal & Fils
Laboratory Novartis
Manufacturer Novartis Pharma AG
Origin Switzerland
ATC H05BA01
Revision Date 15/09/2006

Your comment will appear shortly after approval

Miacalcic Ampoules 100IU° :

Revision Date : 01/09/2015


Effect Frequency
Abdominal pain Common
Allergic reaction Very rare
Anaphylactic shock Very rare
Arthralgia (Pain joint) (Joint ache) Common
Bronchospasm Very rare
C1869086 Common
Cephalea Common
Diarrhoea (Diarrhea) Uncommon
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Common
Face oedema Uncommon
Fatigue Common
Generalized oedema Uncommon
Hypersensitivity Rare
Hypertension Uncommon
Hypocalcaemia Rare
Influenza-like symptoms Uncommon
Injection site reaction Uncommon
Lightheadedness Uncommon
Musculoskeletal pain Uncommon
Nausea Very Common
Neutralizing antibodies Rare
Oedema peripheral Uncommon
Polyuria Uncommon
Pruritus Rare
Rash generalised Uncommon
Redness Very Common
Taste metallic Uncommon
Tremulousness Not known
Urticaria Not known
Visual disturbance Uncommon
Vomiting Very Common

Different Units By MoH Code

Revision Date : 01/04/2002

Revision Date : 15/09/2006

Miacalcic Ampoules 100IU°  MoH 848 :
Form Solution for injection
Packaging Glass Ampoules
Package Size 5x1ml
Strength 100IU
Storage Condition 2-8°C Do not freeze
Stratum N/A
NSSF ✘
Quarantine ✘
Reg. Number 26917
Submission date 01/01/1991
Registration Year 1991
Withdrawn Date 03/02/2020


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info